BioxyTran, Inc. is a clinical-stage pharmaceutical company developing therapeutic drugs to address hypoxia in humans. Its lead candidate, BXT-25, is a bovine hemoglobin-based oxygen-carrying small molecule targeting stroke-related brain hypoxia. Through subsidiary Pharmalectin, the company develops galectin inhibitor-based treatments for viral diseases including COVID-19, with candidates ProLectin-M, ProLectin-I, ProLectin-F, and ProLectin-A targeting mild to severe COVID-19 cases.
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-03 | 2024-12-31 | 0001641172-25-002614 | EDGAR | 52K words |
| 2024-03-22 | 2023-12-31 | 0001493152-24-011014 | EDGAR | 44K words |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010104 | EDGAR | 43K words |
| 2022-04-11 | 2021-12-31 | 0001539497-22-000793 | EDGAR | — |
| 2021-04-09 | 2020-12-31 | 0001785982-21-000076 | EDGAR | — |
| 2020-03-18 | 2019-12-31 | 0001213900-20-006766 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001213900-19-004006 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001213900-18-003761 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001213900-17-003123 | EDGAR | — |
| 2016-07-22 | 2015-12-31 | 0001213900-16-015178 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001493152-26-038327 | EDGAR | 23K words |
| 2025-11-14 | 2025-09-30 | 0001493152-25-023399 | EDGAR | 24K words |
| 2025-08-11 | 2025-06-30 | 0001493152-25-011797 | EDGAR | 22K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010822 | EDGAR | 20K words |
| 2024-10-29 | 2024-09-30 | 0001493152-24-042763 | EDGAR | 26K words |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032356 | EDGAR | 21K words |
| 2024-04-19 | 2024-03-31 | 0001493152-24-015358 | EDGAR | 18K words |
| 2023-11-03 | 2023-09-30 | 0001493152-23-039202 | EDGAR | 21K words |
| 2023-07-31 | 2023-06-30 | 0001493152-23-026050 | EDGAR | 18K words |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016483 | EDGAR | 17K words |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031402 | EDGAR | 22K words |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022572 | EDGAR | 20K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001493152-26-036977 | EDGAR | 1K words |
| 2026-03-20 | 0001493152-26-011755 | EDGAR | 1K words |
| 2026-03-13 | 0001493152-26-010045 | EDGAR | 1K words |
| 2026-03-02 | 0001493152-26-008475 | EDGAR | 1K words |
| 2026-02-17 | 0001493152-26-006891 | EDGAR | 1K words |
| 2026-02-11 | 0001493152-26-006081 | EDGAR | 1K words |
| 2026-01-05 | 0001493152-26-000418 | EDGAR | 1K words |
| 2025-12-15 | 0001493152-25-027639 | EDGAR | 1K words |
| 2025-01-22 | 0001493152-25-003136 | EDGAR | 1K words |
| 2025-01-13 | 0001493152-25-001891 | EDGAR | 3K words |
203 total filings indexed. 171 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001445815 |
| Ticker | BIXT |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Headquarters | Needham, MA |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BIXT (~200 tokens, structured JSON with cryptographic provenance)